Rock Brook client and ACEC NY 2021 Engineering Excellence Awards nominee, Celularity, was recently featured on CNBC for their work in testing stem cell therapy as a viable treatment for Covid-19 patients.  Rock Brook is proud to have helped transform this 150,000 square foot building from office space to a world class pharmaceutical manufacturing site in Florham Park, NJ. Celularity challenged the team to deliver a finished FDA validated space in ten months; a process that ordinarily would span two and a half years for a project of this size. Rock Brook is proud to have worked with this client to deliver a first rate facility through innovative thinking and engineering design.

To view this story on CNBC, please click the link to be directed to their website.